Community Care Rx nears 500,000 Part D enrollments

Article

MemberHealth Inc. announced that Community Care Rx, its Medicare Part D Prescription Drug Plan (PDP), will soon reach 500,000 enrollments. CCRx, a collaborative effort among MemberHealth, Computer Sciences Corp., and NCPA, is one of 10 Medicare-approved PDPs available to Medicare beneficiaries in the U.S. Commenting on the CCRx plan, NCPA executive VP/CEO Bruce Roberts, R.Ph., stated that "pharmacists have embraced the CCRx plans because they encourage them to continue the face-to-face contact with their patients."

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Related Content
Q&A: Pharmacists Play Essential Role in Insulin Therapy Success

Q&A: Pharmacists Play Essential Role in Insulin Therapy Success

Killian Meara;Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
July 15th 2025
Article

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

Killian Meara;Jennifer Gershman, PharmD, CPh, PACS;Hailey Choi, PharmD, BCACP, CDCES
July 15th 2025
Podcast

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

CGRP Medication Did Not Prevent Cluster Headache Attacks

CGRP Medication Did Not Prevent Cluster Headache Attacks

Ashley Gallagher
July 15th 2025
Article

Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.

The Overarching Implications of PBM Reform on the State Level

The Overarching Implications of PBM Reform on the State Level

Brian Nowosielski;Brett Barker, PharmD
July 10th 2025
Podcast

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.

Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare

Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare

Ashley Gallagher;Buddy Carter, BSPharm
July 15th 2025
Article

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management

Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management

Brian Nowosielski;Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES
July 15th 2025
Article

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.

© 2025 MJH Life Sciences

All rights reserved.